NCT01584206View on ClinicalTrials.gov

Sitosterolemia Metabolism

NACompletedINTERVENTIONAL
Enrollment

8

Participants

Timeline

Start Date

April 30, 2012

Primary Completion Date

August 31, 2013

Study Completion Date

December 31, 2016

Conditions
Sitosterolemia
Interventions
DRUG

Ezetimibe

10mg ezetimibe/day, at least 4 months

Trial Locations (1)

R3T 2N2

Richardson Centre for Functional Foods and Nutraceuticals, Winnipeg

All Listed Sponsors
lead

University of Manitoba

OTHER

NCT01584206 - Sitosterolemia Metabolism | Biotech Hunter | Biotech Hunter